FindTrial
Sign In

Small Graft Size and Hepatocellular Carcinoma Outcomes in Adult-to-Adult Living Donor Liver Transplantation: Multicentric Retrospective Observational Study

Small Graft Size and Hepatocellular Carcinoma Outcomes in Adult-to-Adult Living Donor Liver Transplantation: Multicentric Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0009446
Enrollment
2500
Registered
2024-05-17
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Yonsei University Health System, Severance Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with hepatocellular carcinoma who received living donor liver transplants from May 2014 to December 2021.

Exclusion criteria

Exclusion criteria: 1. Age<18 2. Deceased donor liver transplantation

Design outcomes

Primary

MeasureTime frame
Recurrence of Hepatocellular carcinoma, Death—

Secondary

MeasureTime frame
Recurrence free survival—

Countries

Korea, Republic of

Contacts

Public ContactDeok-Gie Kim

Yonsei University Health System, Severance Hospital

mppl01@yuhs.ac+82-2-2228-2133

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026